IS Cataract Awareness MonthRetina specialist, chief eye surgeon and CEO at The Eye Hospital Dr Ronnie Bhola is raising the ...

A 28-year-old man who started using the injectable medication on Saturday (7 June) has opened up on his experience so far ...

WEIGHT loss jabs could one day be dished out like statins, England’s top doctor says. Professor Sir Stephen Powis, medical ...

Eli Lilly ( LLY 0.36%) has been a great growth pick for investors over the past few years. The pharma company, thanks to its ...

Patients with prior treatment for diabetic macular edema (DME) may require more frequent dosing of aflibercept (Eylea), according to a subgroup analysis of the PHOTON trial presented at the recent ...

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

A WOMAN has shared how she lost a staggering 9.5 stone being on Mounjaro, but said there was a dark side that no one talks ...

A new study published in the Obesity Journal found that anti-obesity injections may have a lesser impact on weight loss in a real-world context compared to clinical trials, as patients tend to ...

Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.

A Kettering General Hospital eye team have won a national diabetes excellence award for the service they provide at a new one ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...